Zosano Pharma Corporation (ZSAN)
Zosano Pharma has a market cap or net worth of $60.26 million. The enterprise value is $53.67 million.
The latest earnings date was Friday, November 12, 2021 before market open.
|Last Earnings Date||Nov 12, 2021|
Zosano Pharma has 118.35 million shares outstanding. The number of shares has increased by 48.64% in one year.
|Shares Change (YoY)||+48.64%|
|Shares Change (QoQ)||+6.26%|
|Owned by Insiders (%)||0.48%|
|Owned by Institutions (%)||10.94%|
|EV / Earnings||n/a|
|EV / Sales||58.21|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.29.
|Debt / Equity||0.29|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -72.20%, which is considered low. The company has a ROIC of -79.80%.
|Return on Equity (ROE)||-72.20%|
|Return on Assets (ROA)||-49.00%|
|Return on Capital (ROIC)||-79.80%|
|Revenue Per Employee||$20,489|
|Profits Per Employee||-$690,044|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -42.46% in the last 52 weeks. The beta is 3.12, so Zosano Pharma's price volatility has been higher than the market average.
|52-Week Price Change||-42.46%|
|50-Day Moving Average||0.54|
|200-Day Moving Average||0.66|
|Average Volume (30 Days)||2,679,725|
Short Selling Information
|Short % of Shares Out||3.83%|
|Short % of Float||3.84%|
|Short Ratio (days to cover)||4.06|
In the last 12 months, Zosano Pharma had revenue of $922,000 and -31.05 million in losses. Earnings per share was -$0.29.
|Earnings Per Share (EPS)||-$0.29|
The company has $17.60 million in cash and $11.01 million in debt, giving a net cash position of $6.60 million or $0.06 per share.
|Cash & Cash Equivalents||17.60M|
|Net Cash Per Share||$0.06|
|Book Value Per Share||0.32|
In the last 12 months, operating cash flow was -$28.04 million and capital expenditures -$5.79 million, giving a free cash flow of -$33.83 million.
|Operating Cash Flow||-28.04M|
|Free Cash Flow||-33.83M|
|FCF Per Share||n/a|
Gross margin is 5.10%, with operating and profit margins of -3,530.48% and -3,367.90%.
Dividends & Yields
Zosano Pharma does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The last stock split was on January 26, 2018. It was a reverse split with a ratio of 1:20.
|Last Split Date||Jan 26, 2018|